Teva has reached an agreement in principle to settle a drug-price-fixing case. The terms haven’t been disclosed.

We’ve made it all the way through a dispute about prices and still can’t get a price.

The case was brought by forty-five states, Washington, D.C., and two U.S. territories.

That’s a fairly large group to assemble over a prescription. I usually just stand at the counter and look disappointed.

The states alleged that Teva and other drugmakers agreed to preserve their “fair share” of generic-drug markets while raising prices.

I would have liked a fair share of the money I brought to the pharmacy. I seem to have joined the wrong group.

They said Teva raised prices on about 112 generic drugs and colluded with competitors on at least 86, sometimes pushing increases past 1,000%.

These remain allegations. An agreement in principle is not a finding that they’re true.

The judge has put the case on hold. Neither Teva nor the Connecticut attorney general’s office immediately answered Reuters’ requests for comment.

Fine. They’ve agreed on something.

Apparently the public will get the non-drowsy explanation later.

The Daily Heckler: five or six selected stories.
Political satire for your morning inbox.